New Research Examines Range of Restorative Reproductive Medicine Practices from Evidence-Based Perspective
Six-part series underscores the importance of science-based care, informed patient choice, and timely access to effective fertility treatment
For Immediate Release
Washington, DC—Fertility and Sterility, the flagship publication of the American Society for Reproductive Medicine (ASRM), has published a new six-part series examining the evidence behind fertility optimization approaches that have gained attention amid growing political and public debate over reproductive medicine, including approaches associated with Restorative Reproductive Medicine (RRM) and the Make America Healthy Again (MAHA) movement.
RRM is often promoted as a way to identify and treat underlying reproductive health conditions, such as endometriosis, polycystic ovary syndrome (PCOS), ovulatory disorders, or hormonal imbalances. While some of these practices overlap with evidence-based fertility care when used appropriately, RRM and related approaches are increasingly being positioned in policy and advocacy debates as alternatives to assisted reproductive technologies (ART), including in vitro fertilization (IVF), despite limited evidence showing they are as effective as established treatment options.
The series examines a range of RRM-aligned practices, from lifestyle changes and cycle tracking to medical and surgical treatments, against current standards of evidence-based medicine:
- The Effectiveness and Safety of Restorative Reproductive Medicine: A Systematic Review, by Deanna Ganci et al.: This review finds no high-quality evidence demonstrating that RRM is as effective as ART. Many existing studies were excluded due to poor design, including the absence of control groups.
- Optimization of Conception with Intercourse for Women with Infertility, by David Boedeker et al.: This paper evaluates commonly promoted RRM interventions, including treatments for inflammatory conditions, vitamin deficiencies, immune factors, and luteal phase abnormalities. Aside from select endocrine and ovulation disorders, the authors find limited evidence supporting their effectiveness.
- Diet, Lifestyle Factors and Human Infertility: What We Know, What We Wish We Knew, and What We May Never Know, by Jorge Eduardo Chavarro et al.: While diet, exercise, and substance use are frequently cited as contributors to declining fertility, the authors conclude that current evidence is insufficient to support strong clinical recommendations and call for further research alongside evidence-based care.
- Menstrual Tracking Technologies and Fertility: Evaluating Accuracy, Utility, and Time to Pregnancy, by Hannah C. Milad et al.: While identifying the fertile window is important for those trying to conceive, the effectiveness of cycle tracking tools varies widely. The study highlights the role of data quality, usability, access, and psychological factors in determining the real-world impact.
- Surgical Interventions to Maximize Fertility, by Leigh Ann Humphries et al.: Evidence supporting surgical treatment for infertility related conditions—such as polyps, fibroids, tubal disease, or unexplained infertility—is variable and often limited. The authors recommend that decisions be guided by comparative effectiveness data, patient characteristics, and individual family-building goals.
- Data Driven Analysis of Fertility Optimization, by Eve C. Feinberg and Marcelle Cedars: As political perspectives increasingly intersect with clinical care, the authors emphasize that treatment decisions must remain grounded in evidence-based medicine. They highlight gaps in current knowledge and call for further research to emphasize women’s health, optimize pregnancy outcomes, and support individualized care, while underscoring the importance of informed patient choice.
For almost a century, the American Society for Reproductive Medicine (ASRM) has been the global leader in multidisciplinary reproductive medicine research, ethical practice, and education. ASRM impacts reproductive care and science worldwide by creating funding opportunities for advancing reproduction research and discovery, by providing evidence-based education and public health information, and by advocating for reproductive health care professionals and the patients they serve. With members in more than 100 countries, the Society is headquartered in Washington, DC, with additional operations in Birmingham, AL. www.asrm.org
For media inquiries regarding this press release contact:
Sean Tipton
ASRM Chief Advocacy and Policy Officer
E: stipton@asrm.org
Anna Hovey
Advocacy Engagement Specialist
E: ahovey@asrm.org
J. Benjamin Younger Office of Public Affairs
726 7th St. SE
Washington, DC 20003
Tel: (202) 863-2494
Press Releases
Check out these press releases as well
Half of Infertility Cases Involve Men. Why Does Care Still Treat It as a Women’s Issue?
Since 1989, National Infertility Awareness Week (NIAW) has marked a critical moment each April to elevate public understanding of infertility and push for better care.
National Infertility Awareness Week Highlights Record IVF Births, Growing Demand for Fertility Care
IVF births surpass 100,000 in one year, highlighting demand for fertility care as ASRM urges awareness, reduced stigma, and expanded access nationwide.
ASRM Center for Policy and Leadership Warns Federal Funding Cuts Are Undermining Reproductive Health Infrastructure
Federal funding cuts to NIH, CDC, and FDA threaten reproductive health research, patient safety, and access to care, warns new ASRM policy report.